ProCE Banner Activity

Expanding Therapeutic Choices in Atopic Dermatitis: Targeting Immunoinflammatory Pathways in AD

Slideset

The understanding of atopic dermatitis (AD) pathogenesis has been rapidly expanding over the past several years, leading to the development of multiple new therapies. View these slides to learn about advances in targeting the immunoinflammatory pathways of AD.

Released: July 17, 2023

Share

Faculty

Benjamin Ungar

Benjamin Ungar, MD

Director, Alopecia Center of Excellence
Director, Rosacea & Seborrheic Dermatitis Clinic
Assistant Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

This activity is supported by educational grants from AbbVie Inc, Galderma, and Lilly.

AbbVie Inc.

Galderma

Lilly